Blog

Thinking out loud about FHIR, genomics, and the future of care delivery.

Technical depth, clinical context, and the standards work happening at the intersection of precision medicine and health interoperability.

Why Individual Agent Matching Changes the Tumor Board

The clinical case for matching variants to individual agents — erlotinib vs. gefitinib vs. osimertinib — rather than drug classes.

OncologyMTBCIViC
Coming Soon

Building to HL7 FHIR R6 From the Inside Out

Why we chose FHIR R6 before it was finalized, and what that decision means for interoperability with Epic, Cerner, and any SMART-enabled system.

FHIR R6InteroperabilityStandards
Coming Soon

Pharmacogenomics Belongs to Every Specialty

The same CYP2D6 result matters to the oncologist, the cardiologist, the psychiatrist, and the primary care physician. Here’s why most platforms miss this.

PharmacogenomicsCDSClinical
Coming Soon